logo

For the Inventor, By the Inventor

Corpus Christi, TX, United States of America

Joseph A McDonough

This inventor holds 7 USPTO granted patents. Top assignee: Hoechst Celanese Corporation. Active years: 1992-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A McDonough. Retrieved from https://idiyas.com/inventor/joseph-a-mcdonough-avfiwhgv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Corpus Christi, TX (US) (1992 - 1995)
  • West Greenwich, RI (US) (1997)

Company Filing History:

goldMedal7 out of 1,194 
 
Hoechst Celanese Corporation
 patents

Years Active: 1992-1997

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5696274 - Syntheses based on 2-hydroxyacetophenone (1997-12-09),
2. 5459266 - Substituted pyrazines (1995-10-17),
3. 5430189 - Process for preparing substituted and unsubstituted arylalkylamines (1995-07-04),
4. 5319142 - Process for preparing substituted and unsubstituted arylalkylamines (1994-06-07),
5. 5220067 - Process for the preparation of arylethylamines and substituted (1993-06-15),
6. 5220066 - Process for the preparation of arylethylamines and substituted (1993-06-15),
7. 5175368 - Process for the preparation of arylalkylamines and substituted (1992-12-29),

Title: Joseph A. McDonough: Innovator in Chemical Synthesis

Introduction

Joseph A. McDonough is a notable inventor based in Corpus Christi, TX (US). He has made significant contributions to the field of chemical synthesis, holding a total of 7 patents. His work focuses on developing innovative processes that are both cost-effective and commercially viable.

Latest Patents

One of McDonough's latest patents involves the synthesis based on 2-hydroxyacetophenone. This invention provides flexible methods for manufacturing products derived from 2-hydroxyacetophenone (2-HAP). The compounds produced, such as 4-hydroxycoumarin and warfarin-alkali salt, are essential as vitamin K dependent anticoagulants in medical treatments. Additionally, they serve as rodenticides in various doses. The inventive process includes contacting 2-HAP with carbonate ester and an effective base, followed by treatment with an unsaturated ketone and a phase transfer catalyst to yield the final product.

Another significant patent by McDonough is related to novel substituted pyrazines or pyrazine derivatives. These compounds have useful applications as monomers for high-performance polymers, including polyester, polyarylate, and polyimides. The general formula for these novel substituted pyrazines is defined in his patent documentation.

Career Highlights

Joseph A. McDonough is currently associated with Hoechst Celanese Corporation, where he continues to innovate in the field of chemical synthesis. His work has had a substantial impact on the development of new materials and processes.

Collaborations

Throughout his career, McDonough has collaborated with notable colleagues, including Ahmed M. Tafesh and Olan S. Fruchey. These collaborations have further enhanced his research and development efforts.

Conclusion

Joseph A. McDonough is a distinguished inventor whose work in chemical synthesis has led to significant advancements in the field. His innovative patents demonstrate his commitment to developing effective and practical solutions for various applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…